437 related articles for article (PubMed ID: 12697413)
1. Adhesion and migration of extracellular matrix-stimulated breast cancer.
Bartsch JE; Staren ED; Appert HE
J Surg Res; 2003 Mar; 110(1):287-94. PubMed ID: 12697413
[TBL] [Abstract][Full Text] [Related]
2. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
Sung V; Stubbs JT; Fisher L; Aaron AD; Thompson EW
J Cell Physiol; 1998 Sep; 176(3):482-94. PubMed ID: 9699501
[TBL] [Abstract][Full Text] [Related]
3. Breast adenocarcinoma cell adhesion to the vascular subendothelium in whole blood and under flow conditions: effects of alphavbeta3 and alphaIIbbeta3 antagonists.
Gomes N; Vassy J; Lebos C; Arbeille B; Legrand C; Fauvel-Lafeve F
Clin Exp Metastasis; 2004; 21(6):553-61. PubMed ID: 15679053
[TBL] [Abstract][Full Text] [Related]
4. Differences in integrin expression and signaling within human breast cancer cells.
Taherian A; Li X; Liu Y; Haas TA
BMC Cancer; 2011 Jul; 11():293. PubMed ID: 21752268
[TBL] [Abstract][Full Text] [Related]
5. Zinc inhibits magnesium-dependent migration of human breast cancer MDA-MB-231 cells on fibronectin.
Lymburner S; McLeod S; Purtzki M; Roskelley C; Xu Z
J Nutr Biochem; 2013 Jun; 24(6):1034-40. PubMed ID: 23026493
[TBL] [Abstract][Full Text] [Related]
6. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.
Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR
BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521
[TBL] [Abstract][Full Text] [Related]
7. In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix.
Gui GP; Puddefoot JR; Vinson GP; Wells CA; Carpenter R
Br J Surg; 1995 Sep; 82(9):1192-6. PubMed ID: 7551993
[TBL] [Abstract][Full Text] [Related]
8. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
Ahmed N; Riley C; Rice G; Quinn M
Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
[TBL] [Abstract][Full Text] [Related]
9. Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells.
Ray AM; Schaffner F; Janouskova H; Noulet F; Rognan D; Lelong-Rebel I; Choulier L; Blandin AF; Lehmann M; Martin S; Kapp T; Neubauer S; Rechenmacher F; Kessler H; Dontenwill M
Biochim Biophys Acta; 2014 Sep; 1840(9):2978-87. PubMed ID: 24810979
[TBL] [Abstract][Full Text] [Related]
10. alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells.
Vacca A; Ria R; Presta M; Ribatti D; Iurlaro M; Merchionne F; Tanghetti E; Dammacco F
Exp Hematol; 2001 Aug; 29(8):993-1003. PubMed ID: 11495705
[TBL] [Abstract][Full Text] [Related]
11. Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components.
van der Pluijm ; Vloedgraven H; Papapoulos S; Löwick C; Grzesik W; Kerr J; Robey PG
Lab Invest; 1997 Dec; 77(6):665-75. PubMed ID: 9426405
[TBL] [Abstract][Full Text] [Related]
12. A novel monoclonal antibody, L1A3, is directed to the functional site of the alpha v integrin subunit.
Deryugina EI; Strongin A; Yu C; Bourdon MA
Hybridoma; 1996 Aug; 15(4):279-88. PubMed ID: 8880215
[TBL] [Abstract][Full Text] [Related]
13. Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity.
Maity G; Choudhury PR; Sen T; Ganguly KK; Sil H; Chatterjee A
Tumour Biol; 2011 Feb; 32(1):129-38. PubMed ID: 20821288
[TBL] [Abstract][Full Text] [Related]
14. Thrombin stimulates integrin β1-dependent adhesion of human pancreatic cancer cells to vitronectin through protease-activated receptor (PAR)-1.
Kanemaru M; Maehara N; Iwamura T; Chijiiwa K
Hepatogastroenterology; 2012; 59(117):1614-20. PubMed ID: 22683980
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
[TBL] [Abstract][Full Text] [Related]
16. Altered cell-matrix contact: a prerequisite for breast cancer metastasis?
Gui GP; Puddefoot JR; Vinson GP; Wells CA; Carpenter R
Br J Cancer; 1997; 75(5):623-33. PubMed ID: 9043016
[TBL] [Abstract][Full Text] [Related]
17. Induction of alpha v beta 3 integrin-mediated attachment to extracellular matrix in beta 1 integrin (CD29)-negative B cell lines.
Stupack DG; Shen C; Wilkins JA
Exp Cell Res; 1992 Dec; 203(2):443-8. PubMed ID: 1281112
[TBL] [Abstract][Full Text] [Related]
18. Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines.
Witkowski CM; Rabinovitz I; Nagle RB; Affinito KS; Cress AE
J Cancer Res Clin Oncol; 1993; 119(11):637-44. PubMed ID: 7688749
[TBL] [Abstract][Full Text] [Related]
19. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix.
Gronthos S; Simmons PJ; Graves SE; Robey PG
Bone; 2001 Feb; 28(2):174-81. PubMed ID: 11182375
[TBL] [Abstract][Full Text] [Related]
20. Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
Belvisi L; Riccioni T; Marcellini M; Vesci L; Chiarucci I; Efrati D; Potenza D; Scolastico C; Manzoni L; Lombardo K; Stasi MA; Orlandi A; Ciucci A; Nico B; Ribatti D; Giannini G; Presta M; Carminati P; Pisano C
Mol Cancer Ther; 2005 Nov; 4(11):1670-80. PubMed ID: 16275988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
